Cipla Ltd.

NSE: CIPLA | BSE: 500087 | ISIN: INE059A01026 | Industry: Pharmaceuticals
| Mid-range Performer
1328.1000 14.10 (1.07%)
NSE Oct 22, 2026 15:06 PM
Volume: 510.1K
 

logo
Cipla Ltd.
31 Oct 2025
1328.10
1.07%
buy
by Axis Direct
Target: 1700 | Upside : 28.0%
Axis Direct
We remain positive on the stock with a BUY rating and arrive at a TP of Rs 1,700/share.
 
Number of FII/FPI investors increased from 917 to 942 in Sep 2026 qtr.
More from Cipla Ltd.
Recommended
Market trades lower, Garware Hi-Tech raises FY27 EBITDA margin outlook by 200 bps
Trendlyne Marketwatch | 22 Oct 2026, 02:44PM
Indian IT’s best week since 2008. Is the comeback real?
The Baseline | 22 Oct 2026, 12:00PM
Indian market boosts Cipla in Q4 despite inventory write-off, new product launches will be key
| 20 May 2022, 07:24PM